The impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients: a retrospective before-after study

BACKGROUND: The international guidelines recommend the administration of trimethoprim-sulfamethoxazole (TMP-SMX) as Pneumocystis jiroveci pneumonia (PJP) prophylaxis for six months after transplantation. The aim of this study is to evaluate the influence of TMP-SMX prophylaxis on the occurrence of a...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Infect Dis
Auteurs principaux: Singh, Ramandeep, Bemelman, Frederike J., Hodiamont, Caspar J., Idu, Mirza M., ten Berge, Ineke J. M., Geerlings, Suzanne E.
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2016
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4766656/
https://ncbi.nlm.nih.gov/pubmed/26912326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-016-1432-3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires